Altimmune, Inc. (ALT) Tops Q3 EPS by 6c

Altimmune, Inc. (NASDAQ: ALT) reported Q3 EPS of ($0.21), $0.06 better than the analyst estimate of ($0.27). Revenue for the quarter came in at $5 thousand versus the consensus estimate of $2.14 thousand.

For earnings history and earnings-related data on Altimmune, Inc. (ALT) click here.

You May Also Be Interested In

• ​Trump said he was unaware of his earnings from crypto
• Trump: 40-60% of chip manufacturing will be in the U.S. - CNBC Interview
• RBC Capital Upgrades GEA Group AG (G1A:GR) (GEAGY) to Outperform